Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMD
#442
Revolution Medicines, Inc. Common Stock
152.540
0
USD
+3.76%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.76%
Monthly Change
+57.91%
6 month change
+175.34%
Year Change
+175.34%
Previous Close
147.010
0
Open
152.540
0
Bid
Ask
Low
152.540
0
High
152.540
0
Volume
160
Markets
US Stock Market
Healthcare
RVMD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
185.91 M
186.27 M
186.93 M
193.32 M
198.17 M
—
Valuation ratios
Enterprise value
7.59 B
6.25 B
6.47 B
8.81 B
15.4 B
36.94 B
Price to earnings ratio
-12.22
-8.82
-8.16
-9.02
-13.39
-39.38
Price to sales ratio
—
5 246.72
3 688.56
3 511.79
—
—
Price to cash flow ratio
-13.16
-10.35
-9.64
-11.31
-16.87
-48.17
Price to book ratio
3.24
0.81
0.84
1.09
9.28
12.02
Enterprise value to EBITDA ratio
-10.44
-7.63
-7.01
-8.33
-12.82
-35.79
Profitability ratios
Return on assets %
-0.08
-0.09
-0.1
-0.14
-0.15
-0.48
Return on equity %
-0.09
-0.1
-0.13
-0.19
-0.22
-0.65
Return on invested capital %
-309.76
—
—
—
-310.11
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-18.99 K
-43.4 K
-50.12 K
-43.31 K
-155.81 K
EBITDA margin %
—
-19.51 K
-44.24 K
-50.57 K
-43.4 K
-157.72 K
Net margin %
—
-16.83 K
-40.62 K
-48.52 K
-43.7 K
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.2
13.46
11.79
8.05
7.14
40.45
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.82
-1.03
-1.18
-1.1
-1.44
-4.75
EBIT per share
-1.29
-1.27
-1.4
-1.66
-1.9
-6.23
EBITDA per share
-1.33
-1.32
-1.43
-1.68
-1.91
-6.33
Total debt per share
—
—
—
—
—
—
Cash per share
13.65
11.18
11.33
10.21
10.65
43.37
Net current asset value per share
13.88
11.35
11.54
10.45
10.91
44.25
Tangible book value per share
13.08
10.67
9.52
8.07
8.21
36.46
Working capital per share
12.9
10.5
10.56
9.15
9.39
39.6
Book value per share
13.5
11.05
9.89
8.44
8.58
37.96
News
Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
Stocks Settle Higher in Hopes for an Agreement to End the Iran War
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)
Stocks Recover as Oracle Leads Software Companies Higher
Stocks Retreat as US Set to Blockade the Strait of Hormuz
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?
Harbor Health Care ETF Q4 2025 Portfolio Review